Overview

Sitagliptin in Non-Diabetic Patients Undergoing General Surgery

Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare sitagliptin with a placebo for the prevention of high glucose after general surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Emory University
Treatments:
Insulin
Insulin Aspart
Insulin Detemir
Insulin Glargine
Insulin Lispro
Insulin, Globin Zinc
Sitagliptin Phosphate